Publications of Michael Wierer

Journal Article (26)

21.
Journal Article
Doll, S.; Kriegmair, M. C.; Santos, A.; Wierer, M.; Coscia, F.; Neil, H. M.; Porubsky, S.; Geyer, P. E.; Mund, A.; Nuhn, P. et al.; Mann, M.: Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient. Molecular Oncology 12 (8), pp. 1296 - 1307 (2018)
22.
Journal Article
Wierer, M.; Mann, M.: Proteomics to study DNA-bound and chromatin-associated gene regulatory complexes. Human Molecular Genetics 25 (R2), pp. R106 - R114 (2016)
23.
Journal Article
Wobst, J.; von Ameln, S.; Wolf, B.; Wierer, M.; Dang, T. A.; Sager, H. B.; Tennstedt, S.; Hengstenberg, C.; Koesling, D.; Friebe, A. et al.; Braun, S. L.; Erdmann, J.; Schunkert, H.; Kessler, T.: Stimulators of the soluble guanylyl cyclase: promising functional insights from rare coding atherosclerosis-related GUCY1A3 variants. Basic Research in Cardiology 111 (4), 51 (2016)
24.
Journal Article
Beringer, M.; Pisano, P.; Di Carlo, V.; Blanco, E.; Chammas, P.; Vizan, P.; Gutierrez, A.; Aranda, S.; Payer, B.; Wierer, M. et al.; Di Croce, L.: EPOP Functionally Links Elongin and Polycomb in Pluripotent Stem Cells. Molecular Cell 64 (4), pp. 645 - 658 (2016)
25.
Journal Article
Di Stefano, B.; Collombet, S.; Jakobsen, J. S.; Wierer, M.; Luis Sardina, J.; Lackner, A.; Stadhouders, R.; Segura-Morales, C.; Francesconi, M.; Limone, F. et al.; Mann, M.; Porse, B.; Thieffry, D.; Graf, T.: C/EBP alpha creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4. Nature Cell Biology 18 (4), pp. 371 - 381 (2016)
26.
Journal Article
Wright, R. H. G.; Lioutas, A.; Le Dily, F.; Soronellas, D.; Pohl, A.; Bonet, J.; Nacht, A. S.; Samino, S.; Font-Mateu, J.; Vicent, G. P. et al.; Wierer, M.; Trabado, M. A.; Schelhorn, C.; Carolis, C.; Macias, M. J.; Yanes, O.; Oliva, B.; Beato, M.: ADP-ribose-derived nuclear ATP synthesis by NUDIX5 is required for chromatin remodeling. Science 352 (6290), pp. 1221 - 1225 (2016)

Meeting Abstract (1)

27.
Meeting Abstract
Coscia, F.; Lengyel, E.; Duraiswamy, J.; Ashcroft, B.; Bassani-Sternberg, M.; Wierer, M.; Johnson, A.; Wroblewski, K.; Montag, A.; Yamada, S. D. et al.; Mann, M.; Curtis, M.: Proteomics identifies CT45 as a mediator of chemosensitivity and immunotherapy target in ovarian cancer. In Clinical Cancer Research, 24 (15), p. 95 - 95. AACR Special Conference on Addressing Critical Questions in Ovarian Cancer Research and Treatment, Pittsburgh, PA, October 01, 2017 - October 04, 2017. Association for Cancer Research, Denville, NJ (2018)
Go to Editor View